Abstract
The number of new daily infections is one of the main parameters to understand the dynamics of an epidemic. During the COVID-19 pandemic in 2020, however, such information has been underestimated. Here, we propose a retrospective methodology to estimate daily infections from daily deaths, because those are usually more accurately documented. This methodology is applied to Spain and its 19 administrative regions. Our results showed that probable infections during the first wave were between 35 and 42 times more than those officially documented on 14 March, when the national government decreed a national lockdown and 9 times more than those documented by the updated version of the official data. The national lockdown had a strong effect on the growth rate of virus transmission, which began to decrease immediately. Finally, the first inferred infection in Spain is about 43 days before it was officially reported during the first wave. The current official data show delays of 15-30 days in the first infection relative to the inferred infections in 63% of the regions. In summary, we propose a methodology that allows reinterpretation of official daily infections, improving data accuracy in infection magnitude and dates because it assimilates valuable information from the National Seroprevalence Studies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding This work was supported by the University of Alicante [COVID-19 2020-41.30.6P.0016 to CB] and the Ajuntament de Denia through the Montgo-Denia Research Station Agreement [2020-41.30.6O.00.01 to CB]. Acknowledgements We acknowledge Parques Nacionales (Ministerio para la Transicion Ecologica y Reto Demografico, Spain) and Generalitat Valenciana (Regional Government of Valencia, Spain) for the support of the Montgo-Denia Research Station. Editing was provided by Sea Pen Scientific Writing.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Alicante
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The most relevant changes in the manuscript are: (1) As suggested by Reviewer 1, (Lewin 1986; Perez, Monsalve, and Marquez 2015) we have updated our analysis. In the original version of the manuscript, time series of inferred infection ended on 28 April 2020, when the first phase of the National Seroprevalence Study was concluded. Now, we have updated them to 29 November 2020, when the last phase of the same study was finished. That is an extension from 4 to 11 months. REMEDID depends on seroprevalence studies since they are needed to estimate the Case Fatality Ratio (CFR). The extension of time series had a great impact on the results of the study, since new information related to the second wave arose and had to be analyzed. That is the reason for so much changes in the data and result sections. However, the methodology and the discussion are quite similar to the original version. (2) As suggested by the Editorial Board Member, we have included a validation test for REMEDID as a new Appendix. Validation of REMEDID results presented in the manuscript is quite complicated due to the lack of accurate data to compare with. Neither dynamical models could be used since they also need accurate data to be tuned. Thus, we propose a proof of concept based in a modification of REMEDID to make it comparable with available official data. The results are positive.
Data Availability
All data used is available in the manuscript or in the references. The MATLAB code is available in the Supplementary Material.
